Human Immunodeficiency Virus HIV PBMC
Human Immunodeficiency Virus HIV PBMC samples are collected from clinically confirmed HIV donors and cryopreserved. Ideal for examining HIV infection dynamics, immune responses, and viral latency.
| Lot # | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77101 | HIV | 100M | African American | -1 | Male | United States |
Biktarvy
|
118 | ||
| 77101 | HIV | 100M | African American | -1 | Male | United States |
Biktarvy
|
1 | ||
| 73460 | HIV | 100M | Hispanic/Latino | 52 | Male | United States |
biktarvy 50-200-25 MG daily
|
63 | ||
| 72100 | HIV | 50M | Caucasian | 56 | Male | United States |
biktarvy 50-200-25mg QD tamsulosin 0.4mg QD emsam 11mg QD acyclovir 800mg as needed loratadine 10mg QD
|
50 | $1,109.00 | |
| 72469 | HIV | 50M | Caucasian | 40 | Female | United States |
Biktarvy 25mg QD
|
70 | $1,109.00 | |
| 72469 | HIV | 10M | Caucasian | 40 | Female | United States |
Biktarvy 25mg QD
|
11 | $530.00 | |
| 72100 | HIV | 10M | Caucasian | 56 | Male | United States |
biktarvy 50-200-25mg QD tamsulosin 0.4mg QD emsam 11mg QD acyclovir 800mg as needed loratadine 10mg QD
|
12 | $530.00 | |
| 71916 | HIV | 50M | Caucasian | 62 | Male | United States |
Triumeq 600/50/300 Metoprolol 25 mg Losartan 100 mg ASA 8 mg Atorvastatin 20 mg Metformin 500 mg ProAir
|
54 | $1,109.00 | |
| 71936 | HIV | 50M | Caucasian | 45 | Male | United States |
Biktarvy 50mg/200mg/25mg QD Wellbutrin 300mg QD Adderall 10mg QD lamictal 10mg QD Biosil 105mg BID Hair Supplement QD
|
98 | $1,109.00 | |
| 71916 | HIV | 10M | Caucasian | 62 | Male | United States |
Triumeq 600/50/300 Metoprolol 25 mg Losartan 100 mg ASA 8 mg Atorvastatin 20 mg Metformin 500 mg ProAir
|
12 | $530.00 |
High-Quality Human Immunodeficiency Virus HIV PBMC for Research
Human Immunodeficiency Virus HIV PBMC Sample products are sourced from donors clinically diagnosed with HIV and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on HIV infection dynamics, immune response, and viral latency to understand HIV pathogenesis, vaccine responses, and anti-retroviral treatments.
Product Features
- Research Use Only (RUO), cryopreserved PBMC
- Clinically confirmed HIV donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified HIV diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional HIV-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in Human Immunodeficiency Virus pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Human Immunodeficiency Virus HIV PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.